Key result
Cryoballoon ablation was non-inferior to radiofrequency ablation for the treatment of paroxysmal atrial fibrillation, with single-procedure success rates of 42% and 40% respectively at 30 months.
Why the study?
Does cryoballoon ablation provide non-inferior procedural success compared to radiofrequency ablation in patients with drug-refractory paroxysmal atrial fibrillation?
RCT (n=315)
Random number generation software
Does cryoballoon ablation provide non-inferior procedural success compared to radiofrequency ablation in patients with drug-refractory paroxysmal atrial fibrillation?
Cryoballoon ablation is non-inferior to radiofrequency ablation for long-term (30-month) procedural success in patients with drug-refractory paroxysmal atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Supports cryoballoon as alternative to radiofrequency ablation; confirms non-inferior single-procedure success in paroxysmal AF.
BACKGROUND: Effective treatment of paroxysmal atrial fibrillation (AF) is essential for reducing the risk of stroke and heart failure. Cryoballoon (CB) ablation has been developed as an alternative to the use of radiofrequency (RF) energy for electrical isolation of the pulmonary veins. Herein, we provide long-term data regarding the efficacy of CB ablation in comparison to RF. METHODS: FreezeAF was a randomised non-inferiority study comparing CB ablation with RF ablation for the treatment of patients with drug-refractory paroxysmal AF. Procedural success for the long-term follow-up (30 months) was defined as freedom from AF with an absence of persistent complications. RESULTS: Of the 315 patients that were randomised and received catheter ablation, 292 (92.7%) completed the 30-month follow-up (147 in the RF group and 145 in the CB group). The baseline characteristics of the RF and CB groups were similar. Single-procedure success was achieved by 40% of patients in the RF group and 42% of the CB group (p < 0.001 for non-inferiority). When including re-do procedures in the analysis, the multiple procedure success rate was 72% in the RF group and 76% in the CB group. CONCLUSION: The data provide long-term evidence that CB ablation is non-inferior to RF ablation, with high proportions of patients reporting freedom from AF 30 months after the index procedure. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00774566 ; first registered October 16, 2008; first patient included October 20, 2008.
No takes yet. Share an insight, caveat, or question.
Luik et al. (2017) conducted an RCT in Paroxysmal atrial fibrillation (n=315). Cryoballoon ablation vs. Open irrigated radiofrequency ablation was evaluated on Procedural success (freedom from AF with an absence of persistent complications) at 30 months (p=<0.001 for non-inferiority). Cryoballoon ablation was non-inferior to radiofrequency ablation for the treatment of paroxysmal atrial fibrillation, with single-procedure success rates of 42% and 40% respectively at 30 months.
Synapse has enriched 10 related papers. Consider them for comparative context: